Diane D. Liu

<i>KRAS</i>Mutation Is an Important Predictor of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer

Erminia Massarelli, Marileila Varella‐Garcia, Ximing Tang et al. · Clinical Cancer Research · 2007 · 600 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Phase I/II Trial Evaluating the Anti-Vascular Endothelial Growth Factor Monoclonal Antibody Bevacizumab in Combination With the HER-1/Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib for Patients With Recurrent Non–Small-Cell Lung Cancer

Roy S. Herbst, David H. Johnson, Eric D. Mininberg et al. · Journal of Clinical Oncology · 2005 · 536 citations · Full text

Medicine, Oncology, Pharmacology +16

Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation.

Jean‐Charles Soria, Ho‐Young Lee, Janet I. Lee et al. · PubMed · 2002 · 409 citations

Medicine, Genetics, Oncology +17

Epidermal Growth Factor Receptor Copy Number Alterations Correlate With Poor Clinical Outcome in Patients With Head and Neck Squamous Cancer

Stéphane Temam, Hidetoshi Kawaguchi, Adel K. El‐Naggar et al. · Journal of Clinical Oncology · 2007 · 400 citations · Full text

Medicine, Molecular Genetics, Oncology +16

Overexpression of podoplanin in oral cancer and its association with poor clinical outcome

Ping Yuan, Stéphane Temam, Adel K. El‐Naggar et al. · Cancer · 2006 · 305 citations · Full text

Medicine, Oncology, Oral Pathology +17